Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by AFD China Intellectual Property Law OfficeXue Li, Jingjing Wu and Mingzhao Yang of AFD China Intellectual Property Law Office review China’s recent high-level decisions on trademark ‘use’, with valuable lessons for infringement -
Sponsored by Chang Tsi & PartnersMichael Wu and Darren Leng of Chang Tsi & Partners analyse China’s new Patent Law, as the country strives for a competitive IP protection platform on the global stage
-
Sponsored by CCPIT Patent and Trademark Law OfficeGang Hu and Hongxia Wu of CCPIT Patent and Trademark Law Office use practical knowledge to illustrate the evidence rights holders need to effectively protect their IP and win significant damages in China
-
Sponsored by DEQI Intellectual Property Law CorporationYingping Song of DEQI Intellectual Property clarifies the complexities surrounding divisional application strategies in China
-
Sponsored by Wanhuida Intellectual PropertyFeng Zheng and Xiaoyang Yang of Wanhuida outline the various defence mechanisms patentees have at their disposal when facing infringement accusations in China
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law finds encouragement for developers of new chemical entity drugs after the rulings handed down in a battle between AstraZeneca and several generic pharmaceutical companies
